Friulimicin D, a powerful antibiotic employed within the biomedical sector to counteract bacterial infections, distinctly directs its impact towards Gram-positive bacteria, encompassing formidable methicillin-resistant Staphylococcus aureus (MRSA). This exceptional compound demonstrably showcases an elevated level of efficacy in combatting diverse ailments triggered by these virulent microorganisms, consequently endowing it with immense significance as a formidable armamentarium combating antibiotic resistance-inflicted afflictions.
CAT# | R2079 |
CAS | 302327-42-0 |
M.F/Formula | C60H96N14O19 |
M.W/Mr. | 1317.49 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...
Dipeptide diaminobutyroyl benzylamide diacetate, a biologically active polypeptide, classified as a neuropeptide ...
Antazoline is a drug used in the treatment of atrial fibrillation (AF), and its formula is C17H19N3. In fact, th ...
PAC-113, as well as a new type of Trp-rich peptide, is a 12 amino-acid fragment of the saliva protein histatin 5 ...
Cyclotraxin B , a potent antagonist of TrkB receptors, inhibits BDNF-induced TrkB activity (IC50 = 0.30 nM). R ...